Lung and blood early biomarkers for host-directed tuberculosis therapies: Secondary outcome measures from a randomized controlled trial.
第一作者:
Robert S,Wallis
第一单位:
Aurum Institute, Johannesburg, South Africa.;School of Medicine, Vanderbilt University, Nashville, Tennessee, United States of America.;School of Medicine, Case Western Reserve University, Cleveland, Ohio, United States of America.
作者:
医学主题词
人类(Humans);女(雌)性(Female);男(雄)性(Male);成年人(Adult);结核, 肺(Tuberculosis, Pulmonary);抗结核药(Antitubercular Agents);中年人(Middle Aged);肺(Lung);金诺芬(Auranofin);治疗结果(Treatment Outcome)
DOI
10.1371/journal.pone.0252097
PMID
35120127
发布时间
2025-05-30
- 浏览3
PloS one
e0252097页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



